Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| IMPEL NEUROPHARMA INC | 97,990 | reported | 29 Mar 2022 | tx 10+177,990−97,990 |
| MAP Pharmaceuticals, Inc. | 40,000 | reported | 22 Jan 2008 | tx 1+40,000 |
| Neurogene Inc. | 35,000 | reported | 10 Mar 2016 | tx 4+91,650 |
| Sarepta Therapeutics, Inc. | 25,000 | reported | 23 Aug 2010 | tx 6+715,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 Mar 2022 | EXERCISE | IMPEL NEUROPHARMA INC | 24,606 | 1.97 USD | |
| 29 Mar 2022 | EXERCISE | IMPEL NEUROPHARMA INC | 24,606 | 0.00 USD | deriv |
| 26 Jan 2022 | GRANT_AWARD | IMPEL NEUROPHARMA INC | 30,000 | 0.00 USD | deriv |
| 21 Sept 2021 | EXERCISE | IMPEL NEUROPHARMA INC | 53,954 | 2.95 USD | |
| 21 Sept 2021 | EXERCISE | IMPEL NEUROPHARMA INC | 4,650 | 2.46 USD | |
| 21 Sept 2021 | EXERCISE | IMPEL NEUROPHARMA INC | 14,780 | 1.97 USD | |
| 21 Sept 2021 | EXERCISE | IMPEL NEUROPHARMA INC | 53,954 | 0.00 USD | deriv |
| 21 Sept 2021 | EXERCISE | IMPEL NEUROPHARMA INC | 4,650 | 0.00 USD | deriv |
| 21 Sept 2021 | EXERCISE | IMPEL NEUROPHARMA INC | 14,780 | 0.00 USD | deriv |
| 20 Jul 2021 | GRANT_AWARD | IMPEL NEUROPHARMA INC | 50,000 | 0.00 USD | deriv |
| 10 Mar 2016 | GRANT_AWARD | Neurogene Inc. | 35,000 | 0.00 USD | deriv |
| 12 Mar 2015 | GRANT_AWARD | Neurogene Inc. | 25,000 | 0.00 USD | deriv |
| 02 Sept 2014 | PURCHASE | Neurogene Inc. | 400 | 8.22 USD | |
| 08 May 2014 | GRANT_AWARD | Neurogene Inc. | 31,250 | 0.00 USD | deriv |
| 23 Aug 2010 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 09 Feb 2010 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 120,000 | 0.00 USD | deriv |
| 09 Feb 2010 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |
| 26 Jan 2009 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 220,587 | 0.00 USD | deriv |
| 26 Jan 2009 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 229,413 | 0.00 USD | deriv |
| 22 Jan 2008 | GRANT_AWARD | MAP Pharmaceuticals, Inc. | 40,000 | 13.12 USD | deriv |